| SV2A antibodies | |
| This is a review about SV2 antibodies, based on 4 published articles using SV2 antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited SV2 antibody. Information in this review (with links to publications) can be searched freely. |
SIGMA-ALDRICH search Sigma-Aldrich SV2A products
includes other brands or spellings
|
| ih | | Sigma SV2A antibody was tested in immunohistochemistry by Human Protein Atlas. |
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology SV2A products
includes other brands or spellings
|
| ip, wb | | Santa Cruz Biotechnology anti-SV2A antibody was used in western blot and immunoprecipitation to demonstrate that SV2A is the binding site of LEV in the brain and that LEV acts by modulating the function of SV2A. |
KATHLEEN M BUCKLEY (HARVARD MEDICAL SCHOOL)
|
| ic | | Kathleen M. Buckley (Harvard Medical School) mouse monoclonal anti-SV2 antibody was used in immunocytochemistry to study localize GRIP1 splice variant in GABAergic and glutamatergic synapses in the brain. |
DR. K. BUCKLEY (HARVARD)
|
| ih, wb | | Dr. K. Buckley (Harvard) mouse anti synaptic vesicle protein 2 antibody was used in western blot and immunohistochemistry to study differential distribution of vesicle associated membrane protein isoforms in the mouse retina. |
Articles Reviewed |
| 1. David M Sherry et al. Differential distribution of vesicle associated membrane protein isoforms in the mouse retina. 2003 |
| 2. Berkley A Lynch et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. 2004 |
| 3. Erik I Charych et al. A four PDZ domain-containing splice variant form of GRIP1 is localized in GABAergic and glutamatergic synapses in the brain. 2004 |
| 4. Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 |
|